Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Rapid Diagnostic Test for Hepatitis C Developed with Scrapbooking Tool

By LabMedica International staff writers
Posted on 17 Jun 2014
Scientists have used a novel approach to develop a paper-based multiplex diagnostic immunoassay that could help curb the hepatitis C pandemic.

For patients already diagnosed with Hepatitis C virus (HCV), the US Food and Drug Administration (FDA) approved two new treatments in late 2013, and others are on the way. Scientists Xuan Mu, Zhi Zheng, and colleagues, of the Chinese Academy of Medical Sciences (Beijing, China), are solving another critical problem—identifying the millions more who unknowingly have the virus and pass it on. They point out that although HCV infects an estimated 150 million people worldwide, current diagnostic testing involves initial screening then a costly second test for confirmation. The extra office visits, money, and time required for definitive diagnosis means that many people are missed as they cannot or do not follow through.

To make diagnosis much more accessible, the researchers applied the recent development of inexpensive paper-based medical technologies to immunoassay detection of human IgG anti-HCV. In a new report they present a novel approach: taking example from the popular scrapbooking pastime, they used a flower-shaped metal paper-puncher on nitrocellulose paper subtrate. This solved the problem of patterning the highly flammable nitrocellulose—without using heat. The flower shape itself provides multiple testing zones, enabling development of a multiplex test. The immunoassays can be conducted such that both HCV tests can be conducted simultaneously on one patient sample on a single flower-shaped paper – at lower cost and in minutes instead of hours.

The work highlights the potential of microfluidic paper-based immunoassays in tackling the diagnostic challenge for the HCV pandemic as well as other diseases. Xuan M., et al. described the new test in the American Chemical Society journal Analytical Chemistry, May 5, 2014, online, ahead of print.

Related Links:

Chinese Academy of Medical Sciences



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.